AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 10/05/23

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2023 financial results on Tuesday, November 7, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time. ...

2023-09-24 07:37:29 ET Summary Amneal Pharmaceuticals exhibits strong Q2 performance with $599M in revenue and diversification in generics and biosimilars. However, its $2.59B long-term debt overshadows growth, raising concerns over liquidity and future financing options. Inve...

2023-09-06 18:16:56 ET More on Amneal Pharmaceuticals Seeking Alpha’s Quant Rating on Amneal Pharmaceuticals Historical earnings data for Amneal Pharmaceuticals Financial information for Amneal Pharmaceuticals Amneal Pharmaceuticals, Inc. 2023 Q2 - Res...

- Key injectable currently on the U.S. FDA shortage list - Received Competitive Generic Therapy approval designation Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Application...

- 1 st product approval in China represents Amneal’s entry in second largest pharmaceutical market - Expects international expansion will be another key vector for long-term growth and impact Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the &#x...

- Key ADHD medicine on the U.S. FDA shortage product list - Represents another high-value product approval for Amneal Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has received Abbreviated New Drug Applicatio...

- Senior members of the U.S. Government Visit One of Amneal’s 12 Manufacturing Sites Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that a delegation of senior members of the U.S. Department of Health and Human ...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate at the 2023 Wells Fargo Healthcare Conference on September 7, 2023 in Boston. Mr. Pat...

- IPX203 demonstrated statistically significant improvement in daily “Good On” time compared to optimized IR CD/LD, with fewer daily doses Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that JAMA Neurology has published results from the RISE-PD clinical study ...

2023-08-21 16:01:59 ET Are you on the hunt for the most promising penny stocks to invest in for 2023? Join the ever-expanding group of investors who are keen to leverage the booming market. With record-breaking performances by the S&P 500 and Nasdaq this year, there’s a growi...